Intellectual Property India Publishes Patent Application for Salt Form And Crystal Form Of 5-Ht2a Receptor Inverse Agonist, Preparation Method Therefor And Use Thereof

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617097031 A) filed by Luye Innomind Pharma Shijiazhuang Co. , Ltd. on August 11, 2026, for Salt Form And Crystal Form Of 5-Ht2a Receptor Inverse Agonist, Preparation Method Therefor And Use Thereof.

Inventors include Gao, Shuai; Wang, Guanghui; Shi, Zuopan; Qu, Hao; Wu, Yanhua; and Liao, Wensheng.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The present invention relates to a salt form and a crystal form of a 5-HT2A receptor inverse agonist, a preparation method therefor and the use thereof. Specifically, provided are a pharmaceutically acceptable salt of a compound of formula (I), a crystal ...